The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 352:1386 March 31, 2005 Number 13
NextNext

Levodopa and the Progression of Parkinson's Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by The Parkinson Study Group
-PubMed Citation
To the Editor: The measurements of motor responses after treatment with levodopa reported by the Parkinson Study Group (Dec. 9 issue)1 were taken too soon. The brief half-life of blood-borne levodopa is not related to the very slow rates of accumulation and depletion of dopamine retained in the limbic system. Ignoring paired facts that both the full effectiveness and the full limbic depletion of ingested levodopa require nearly 10 weeks, this study obtained skewed results by measuring movement only 2 weeks after the withdrawal of levodopa therapy. The full decline in motor function as the level of limbic dopamine drops . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.